Results 161 to 170 of about 147,929 (284)

Evaluating renal function with intravoxel incoherent motion in a unilateral ureteral obstruction model. [PDF]

Curr Urol
Zhang L, Zhang Z, Mai W, Jiang Z, Shi C, Lai C, Mo X.   +6 more
europepmc   +1 more source

Rapid improvement of renal microcirculatory homeostasis by liraglutide following diabetes induction

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Renal microvascular dysfunction is a central driver of diabetic kidney disease, yet the potential for rapid therapeutic reversal remains obscure. We investigated the effect of short‐term liraglutide on early changes in the renal microcirculation post‐induction of diabetes.
Yuan Li, Weiqi Liu, Yingyu Wang, Bing Wang, Xiang Xu, Bingwei Li, Mingming Liu, Xu Zhang, Ruijuan Xiu   +8 more
wiley   +1 more source

Effects of different dosages of Sodium-glucose cotransporter 2 inhibitors on glucose level change in patients with type 2 diabetes stratified by HbA1c and renal function: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Xiong R, Yang Y, Li Y, Zhang H.
europepmc   +1 more source

Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To compare the effects of individual SGLT2 inhibitors on preventing new‐onset proteinuria in patients with type 2 diabetes and preserved kidney function. Materials and Methods A target trial emulation was performed using commercially available databases, including health checkups and claims data, between April 1, 2014 and March 31, 2023 ...
Hiroki Nobayashi, Michihiro Satoh, Takuo Hirose, Shingo Nakayama, Yutaro Iwabe, Hideaki Hashimoto, Takahisa Murakami, Kouji Okada, Takefumi Mori, Hirohito Metoki   +9 more
wiley   +1 more source

GFR Evaluation Among Patients with Cancer: Insights and Clinical Implications. [PDF]

Cancers (Basel)
Arora A, Shukla P, Srinivasan V, Oteiza LZ, LeMense Z, Vang G, Hanna PE.   +6 more
europepmc   +1 more source

Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Kidney and cardiovascular diseases are highly prevalent among patients with Type 1 diabetes. To date, no randomised clinical trial has reported on the impact of novel cardio‐kidney‐metabolic (CKM) therapies (GLP‐1RA and SGLT2i) on kidney function in this population.
M. Luiza Caramori, Enrico Repetto, Christopher Perkins, Ambarish Pandey, Peter Rossing   +4 more
wiley   +1 more source

Glomerular filtration rate in patients with renal space-occupying masses using combination of SPECT ^99mTc-DTPA renal dynamic imaging and contrast-enhanced CT. [PDF]

Front Oncol
Jia M, Jiang L, Li X, Nie S, Wang B.
europepmc   +1 more source

Low serum transferrin predicts adverse outcome in COVID‐19 and is related to coagulation activity

British Journal of Haematology, EarlyView.
Lukas Lanser, Francesco Robert Burkert, Lis Thommes, Rosa Bellmann‐Weiler, Guenter Weiss   +4 more
wiley   +1 more source

Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population‐Based Comparison

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Diabetes is increasingly recognised as a major contributor to cognitive decline and dementia, but the risk varies by diabetes type and treatment intensity. We compared the risk of all‐cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) among individuals with and without diabetes.
Ji Eun Jun, Seohyun Kim, In‐Kyung Jeong, Jae Hyeon Kim   +3 more
wiley   +1 more source

Can Measuring Glomerular Filtration Finally be Easy? [PDF]

Kidney Int Rep
Husain SA, Popa CA.
europepmc   +1 more source